Black Box Warnings-Implications in Practice

Geriatric Nursing

Volumn 29, Issue 6, 2008, Pages 402-409

  Zarowitz, Barbara J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; CLASSIFICATION; DRUG LABELING; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HUMAN; LEGAL ASPECT; UNITED STATES;

CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); DRUG LABELING; HUMANS; PHARMACEUTICAL PREPARATIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 57049095762     PISSN: 01974572     EISSN: 15283984     Source Type: Journal    
DOI: 10.1016/j.gerinurse.2008.09.005     Document Type: Article

References (6)

1. Wagner A.K., Chan K.A., Dashevsky I., et al. FDA drug prescribing warnings: is the black box half empty or half full?. Pharmacoepidemiol Drug Saf 15 (2006) 387-389
2. Lasser K.E., Allen P.D., Woolhandler S.J., et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 287 (2002) 2215-2220
3. Lasser K.E., Seger D.L., Yu T., et al. Adherence to black box warnings for prescription medications in outpatients. Arch Intern Med 166 (2006) 338-344
4. American Diabetes Association-Standards of medical care in diabetes-2008. Diab Care 31 Suppl (2008) S12-S54
5. GLUCOPHAGE (metformin hydrochloride tablets) and Glucophage XR (metformin extended release tablets). Product information (June 2006), Bristol-Myers Squibb, Princeton, NJ
6. Billingsley, K. Deputy Director of the Center for Healthcare Quality. California Department of Public Health, State of California, Health and Human Services Agency. Memorandum: "Medication Safety: Use of Medications with Boxed Warnings." November 5, 2007. Available at http://www.pharmacy.ca.gov/publications/boxed_warnings.pdf. Cited September 26, 2008.